Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -212,304 | -147,702 | -68,357 | -239,238 | -140,587 |
| Depreciation Amortization | 7,817 | 5,084 | 2,450 | 9,408 | 7,214 |
| Accounts receivable | -29,276 | -25,522 | -6,615 | -57,121 | -40,716 |
| Accounts payable and accrued liabilities | 23,574 | 20,661 | 13,112 | 2,074 | -9,507 |
| Other Working Capital | 21,101 | 16,074 | -6,807 | -28,238 | -31,876 |
| Other Operating Activity | 86,880 | 47,828 | 12,750 | 168,035 | 100,754 |
| Operating Cash Flow | $-102,208 | $-83,577 | $-53,467 | $-145,080 | $-114,718 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -240 | -150 | -98 | -582 | -575 |
| Investing Cash Flow | $-240 | $-150 | $-98 | $-582 | $-575 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 85,000 | 85,000 |
| Debt Repayment | -660 | -349 | -163 | N/A | N/A |
| Common Stock Issued | 53,897 | 20,506 | 2,501 | 271,169 | 270,024 |
| Other Financing Activity | -9,641 | -6,966 | -3,525 | -25,156 | -24,009 |
| Financing Cash Flow | $43,596 | $13,191 | $-1,187 | $331,013 | $331,015 |
| Beginning Cash Position | 386,193 | 386,193 | 386,193 | 200,842 | 200,842 |
| End Cash Position | 327,341 | 315,657 | 331,441 | 386,193 | 416,564 |
| Net Cash Flow | $-58,852 | $-70,536 | $-54,752 | $185,351 | $215,722 |
| Free Cash Flow | |||||
| Operating Cash Flow | -102,208 | -83,577 | -53,467 | -145,080 | -114,718 |
| Capital Expenditure | -240 | -150 | -98 | -582 | -575 |
| Free Cash Flow | -102,448 | -83,727 | -53,565 | -145,662 | -115,293 |